- Risper Wambui, a 17-year-old battling a rare gastrointestinal stromal tumour, announced she is returning home from India to sit her Form Four exams
- The teenager travelled to Mumbai in August 2026 for specialised cancer treatment after Kenyans raised over KSh 2.6 million for her medical expenses
- Risper shared a heartfelt message on Facebook seeking prayers as she prepares to face her KCSE exams while continuing her medication
Seventeen-year-old cancer patient Risper Wambui Muraya has announced she is returning to Kenya from India to sit her 2026 KCSE examinations.
Source: Facebook
She shared the news in a Facebook post on Wednesday, October 21, expressing faith and determination despite her ongoing battle with cancer.
What did Risper Wambui say about her KCSE exam?
"I am coming back home to sit for my Form Four exams while continuing with my medication. I pray that God will help me pass my exams, heal me completely, and help me overcome every challenge I am facing. With God by my side, I believe I will make it," she wrote.
Search option is now available at TUKO! Feel free to search the content on topics/people you enjoy reading about in the top right corner ;)
Risper's story has touched the hearts of many Kenyans since she was diagnosed with a gastrointestinal stromal tumour, a rare cancer affecting the digestive system.
Her condition deteriorated to the point where the disease reportedly spread to her liver, and doctors advised her family to seek specialised treatment in India, as the care she required was not readily available locally.
Her family needed to raise KSh 2.6 million to cover travel and treatment costs. An initial local fundraiser organised by her mother drew no attendees, but everything changed when Risper shared an emotional video appeal, telling Kenyans:
"Do not let me die at such a young age."
The clip spread rapidly online, attracting support from philanthropists including Ndungu Nyoro and Dennis Njuguna, popularly known as Cukura ya Nairobi. Contributions eventually surpassed the initial target.
Risper and her mother arrived in Mumbai in August 2026, where doctors confirmed the GIST diagnosis and carried out further mutation tests to determine the most suitable targeted medication.
The treatment plan centred on drug therapy rather than immediate surgery. By October, she was reportedly still appealing for an additional KSh 1.5 million to fund the specialised medication.
When did KCSE 2026 start?
The 2026 KCSE examinations, administered by the Kenya National Examinations Council, kicked off on Monday, October 19, with a record 1,048,355 candidates registered nationally.
Written papers are scheduled to begin on October 28, giving Risper a window to return and settle in before the main theory examinations get underway in November.
See the post below:
Kenyans react
Kenyans flooded her post with warm messages of support:
Teresia Njeri:
"Congratulations baby with God all things are possible"
Jimmie Vardy:
"Quick recovery"
Ndwish:
"May the success be yours and be your portion"
Wairish Kamande:
"All the best, Risper"
Uria wari Cukura ya Nairobi:
"Wow, it shall be well, cute girl; you shall pass the exam and beat the illness"
José Wa Pangani:
"Quick recovery, kamum. Did you carry your literature and fasihi books...Just for revision? May you pass with flying colors"
What is the update on Risper's health?
TUKO.co.ke also highlighted more facts about Risper's treatment in India, where doctors confirmed her stomach growth is a gastrointestinal stromal tumour, or GIST.
Her treatment plan depends on pending mutation test results, which will help doctors identify the most suitable medicine.
Source: TUKO.co.ke